BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33481211
Number of visits today
9198
Number of downloads
16667456
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Espinosa de los Monteros AL, Carrasco CA, Albarrán AA, Gadelha M, Abreu A, Mercado M. The role of primary pharmacological therapy in acromegaly. Pituitary 2014;17 Suppl 1:S4-10. [PMID: 24166706 DOI: 10.1007/s11102-013-0530-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Capatina C, Wass JA. 60 YEARS OF NEUROENDOCRINOLOGY: Acromegaly. J Endocrinol 2015;226:T141-60. [PMID: 26136383 DOI: 10.1530/JOE-15-0109] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 8.1] [Reference Citation Analysis]
2 Bronstein MD, Bruno OD, Abreu A, Mangupli R, Mercado M. A practical approach to acromegaly management in Latin America. Pituitary 2014;17 Suppl 1:S30-5. [PMID: 24258208 DOI: 10.1007/s11102-013-0531-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
3 Mercado M. Somatostatin analog withdrawal in patients with acromegaly: an elusive goal? Endocrine 2014;46:368-9. [DOI: 10.1007/s12020-014-0262-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Centanni M, Cellini M. Efficacia e sicurezza del trattamento con un impianto sottocutaneo di octreotide in pazienti con acromegalia. L'Endocrinologo 2014;15:43-44. [DOI: 10.1007/s40619-014-0008-y] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345